The Valley Desk

NCT04280718 · Interventional trial

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

Overall registry status Active not recruiting

Phase 2

Conditions Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov